Home Casteddu.com FAQ My Amedeo About Flying Publisher   

The Medical Article of the Year 2008


  Ovarian Neoplasms

  Free Subscription


Articles published in Cancer

Retrieve available abstracts of 54 articles:
HTML format



Single Articles


    June 2008
  1. PAL T , Permuth-Wey J, Sellers TA
    A review of the clinical relevance of mismatch-repair deficiency in ovarian cancer.
    Cancer. 2008;.
    PubMed     Related articles    Abstract available


    May 2008
  2. CIBULL ML , Karabakhtsian RG
    Editorial. Endometrioid epithelial ovarian cancer.
    Cancer. 2008;112:2108-11.
    PubMed     Related articles   


  3. DI GIORGIO A , Naticchioni E, Biacchi D, Sibio S, et al
    Cytoreductive surgery (peritonectomy procedures) combined with hyperthermic intraperitoneal chemotherapy (HIPEC) in the treatment of diffuse peritoneal carcinomatosis from ovarian cancer.
    Cancer. 2008;.
    PubMed     Related articles    Abstract available


    April 2008
  4. ZIVANOVIC O , Barakat RR, Sabbatini PJ, Brown CL, et al
    Prognostic factors for patients with stage IV epithelial ovarian cancer receiving intraperitoneal chemotherapy after second-look assessment: results of Long-Term Follow-up.
    Cancer. 2008;.
    PubMed     Related articles    Abstract available


  5. AZAD NS , Annunziata CM, Steinberg SM, Minasian L, et al
    Lack of reliability of CA125 response criteria with anti-VEGF molecularly targeted therapy.
    Cancer. 2008;112:1726-32.
    PubMed     Related articles    Abstract available


  6. HUANG L , Cronin KA, Johnson KA, Mariotto AB, et al
    Improved survival time: What can survival cure models tell us about population-based survival improvements in late-stage colorectal, ovarian, and testicular cancer?
    Cancer. 2008;.
    PubMed     Related articles    Abstract available


    March 2008
  7. VON GRUENIGEN V , Daly B, Gibbons H, Hutchins J, et al
    Indicators of survival duration in ovarian cancer and implications for aggressiveness of care.
    Cancer. 2008;.
    PubMed     Related articles    Abstract available


  8. CHAN JK , Tian C, Monk BJ, Herzog T, et al
    Prognostic factors for high-risk early-stage epithelial ovarian cancer: a gynecologic oncology group study.
    Cancer. 2008;.
    PubMed     Related articles    Abstract available


  9. STOREY DJ , Rush R, Stewart M, Rye T, et al
    Endometrioid epithelial ovarian cancer : 20 years of prospectively collected data from a single center.
    Cancer. 2008;.
    PubMed     Related articles    Abstract available


    February 2008
  10. NOSKE A , Weichert W, Niesporek S, Roske A, et al
    Expression of the nuclear export protein chromosomal region maintenance/exportin 1/Xpo1 is a prognostic factor in human ovarian cancer.
    Cancer. 2008;.
    PubMed     Related articles    Abstract available


  11. FENG W , Marquez RT, Lu Z, Liu J, et al
    Imprinted tumor suppressor genes ARHI and PEG3 are the most frequently down-regulated in human ovarian cancers by loss of heterozygosity and promoter methylation.
    Cancer. 2008;.
    PubMed     Related articles    Abstract available


  12. BARBOLINA MV , Adley BP, Shea LD, Stack MS, et al
    Wilms tumor gene protein 1 is associated with ovarian cancer metastasis and modulates cell invasion.
    Cancer. 2008;.
    PubMed     Related articles    Abstract available


    January 2008
  13. TWOROGER SS , Gertig DM, Gates MA, Hecht JL, et al
    Caffeine, alcohol, smoking, and the risk of incident epithelial ovarian cancer.
    Cancer. 2008;.
    PubMed     Related articles    Abstract available


    December 2007
  14. MAHAJAN NN
    Prophylactic salpingo-oophorectomy in a series of 89 women carrying a BRCA1 or a BRCA2 mutation.
    Cancer. 2007;110:2819.
    PubMed     Related articles   


    November 2007
  15. DOWNS LS JR , Judson PL, Argenta PA, Ghebre R, et al
    A prospective randomized trial of thalidomide with topotecan compared with topotecan alone in women with recurrent epithelial ovarian carcinoma.
    Cancer. 2007;.
    PubMed     Related articles    Abstract available


  16. DONG HP , Kleinberg L, Silins I, Florenes VA, et al
    Death receptor expression is associated with poor response to chemotherapy and shorter survival in metastatic ovarian carcinoma.
    Cancer. 2007;.
    PubMed     Related articles    Abstract available


    October 2007
  17. LEVINE D , Park K, Juretzka M, Esch J, et al
    A phase II evaluation of goserelin and bicalutamide in patients with ovarian cancer in second or higher complete clinical disease remission.
    Cancer. 2007;.
    PubMed     Related articles    Abstract available


    July 2007
  18. DAVIDSON B , Skrede M, Silins I, Shih IM, et al
    Low-molecular weight forms of cyclin E differentiate ovarian carcinoma from cells of mesothelial origin and are associated with poor survival in ovarian carcinoma.
    Cancer. 2007;.
    PubMed     Related articles    Abstract available


  19. GUTH U , Huang DJ, Bauer G, Stieger M, et al
    Metastatic patterns at autopsy in patients with ovarian carcinoma.
    Cancer. 2007;.
    PubMed     Related articles    Abstract available


    June 2007
  20. XIN B , Yokoyama Y, Shigeto T, Futagami M, et al
    Inhibitory effect of meloxicam, a selective cyclooxygenase-2 inhibitor, and ciglitazone, a peroxisome proliferator-activated receptor gamma ligand, on the growth of human ovarian cancers.
    Cancer. 2007;.
    PubMed     Related articles    Abstract available


  21. OUELLET V , Le Page C, Madore J, Guyot MC, et al
    An apoptotic molecular network identified by microarray: On the TRAIL to new insights in epithelial ovarian cancer.
    Cancer. 2007;.
    PubMed     Related articles    Abstract available


  22. POSADAS EM , Kwitkowski V, Kotz HL, Espina V, et al
    A prospective analysis of imatinib-induced c-kit modulation in ovarian cancer: a phase II clinical study with proteomic profiling.
    Cancer. 2007;.
    PubMed     Related articles    Abstract available


    May 2007
  23. MARKMAN M
    Development of an ovarian cancer symptom index: Possibilities for earlier detection.
    Cancer. 2007;.
    PubMed     Related articles   


  24. LAKI F , Kirova YM, This P, Plancher C, et al
    Prophylactic salpingo-oophorectomy in a series of 89 women carrying a BRCA1 or a BRCA2 mutation.
    Cancer. 2007;109:1784-90.
    PubMed     Related articles    Abstract available


    April 2007
  25. GOFF BA , Matthews BJ, Larson EH, Andrilla CH, et al
    Predictors of comprehensive surgical treatment in patients with ovarian cancer.
    Cancer. 2007;.
    PubMed     Related articles    Abstract available


    March 2007
  26. MARKMAN M
    The dangers of "cross-trial" and "cross-retrospective experience" comparisons: examples employing data in the peer-reviewed ovarian cancer literature.
    Cancer. 2007;.
    PubMed     Related articles   


  27. VAN NAGELL JR JR , Depriest PD, Ueland FR, Desimone CP, et al
    Ovarian cancer screening with annual transvaginal sonography: findings of 25,000 women screened.
    Cancer. 2007;.
    PubMed     Related articles    Abstract available


  28. BRISTOW RE , Santillan A, Diaz-Montes TP, Gardner GJ, et al
    Centralization of care for patients with advanced-stage ovarian cancer: a cost-effectiveness analysis.
    Cancer. 2007;.
    PubMed     Related articles    Abstract available


  29. POSADAS EM , Liel MS, Kwitkowski V, Minasian L, et al
    A phase II and pharmacodynamic study of gefitinib in patients with refractory or recurrent epithelial ovarian cancer.
    Cancer. 2007;.
    PubMed     Related articles    Abstract available


    February 2007
  30. MARKMAN M
    Effect of obesity on survival in epithelial ovarian cancer.
    Cancer. 2007;.
    PubMed     Related articles   


  31. FORTIN D , Gendron C, Boudrias M, Garant MP, et al
    Enhanced chemotherapy delivery by intraarterial infusion and blood-brain barrier disruption in the treatment of cerebral metastasis.
    Cancer. 2007;109:751-60.
    PubMed     Related articles    Abstract available


    January 2007
  32. ELIT L , Oliver TK, Covens A, Kwon J, et al
    Intraperitoneal chemotherapy in the first-line treatment of women with stage III epithelial ovarian cancer: a systematic review with metaanalyses.
    Cancer. 2007;.
    PubMed     Related articles    Abstract available


  33. MARTH C , Walker JL, Barakat RR, Casado A, et al
    Results of the 2006 Innsbruck International Consensus Conference on intraperitoneal chemotherapy in patients with ovarian cancer.
    Cancer. 2007;.
    PubMed     Related articles   


  34. MUNSTEDT K , von Georgi R, Franke FE
    Effect of obesity on survival in epithelial ovarian cancer.
    Cancer. 2007;.
    PubMed     Related articles   


  35. SALANI R , Santillan A, Zahurak ML, Giuntoli RL 2nd, et al
    Secondary cytoreductive surgery for localized, recurrent epithelial ovarian cancer: analysis of prognostic factors and survival outcome.
    Cancer. 2007;.
    PubMed     Related articles    Abstract available


    December 2006
  36. UYEI A , Peterson SK, Erlichman J, Broglio K, et al
    Association between clinical characteristics and risk-reduction interventions in women who underwent BRCA1 and BRCA2 testing: a single-institution study.
    Cancer. 2006;107:2745-51.
    PubMed     Related articles    Abstract available


  37. KLEINBERG L , Florenes VA, Silins I, Haug K, et al
    Nuclear expression of survivin is associated with improved survival in metastatic ovarian carcinoma.
    Cancer. 2006;.
    PubMed     Related articles    Abstract available


  38. GOFF BA , Mandel LS, Drescher CW, Urban N, et al
    Development of an ovarian cancer symptom index: possibilities for earlier detection.
    Cancer. 2006;.
    PubMed     Related articles    Abstract available


  39. BLACK SS , Butler SL, Goldman PA, Scroggins MJ, et al
    Ovarian cancer symptom index: possibilities for earlier detection.
    Cancer. 2006;.
    PubMed     Related articles   


  40. LIN YG , Han LY, Kamat AA, Merritt WM, et al
    EphA2 overexpression is associated with angiogenesis in ovarian cancer.
    Cancer. 2006;.
    PubMed     Related articles    Abstract available


    October 2006
  41. ROSEN DG , Mercado-Uribe I, Yang G, Bast RC Jr, et al
    The role of constitutively active signal transducer and activator of transcription 3 in ovarian tumorigenesis and prognosis.
    Cancer. 2006;.
    PubMed     Related articles    Abstract available


    September 2006
  42. DISTELMAIER F , Calaminus G, Harms D, Strater R, et al
    Ovarian small cell carcinoma of the hypercalcemic type in children and adolescents: a prognostically unfavorable but curable disease.
    Cancer. 2006;.
    PubMed     Related articles    Abstract available


  43. CASTELLVI J , Garcia A, Rojo F, Ruiz-Marcellan C, et al
    Phosphorylated 4E binding protein 1: A hallmark of cell signaling that correlates with survival in ovarian cancer.
    Cancer. 2006;.
    PubMed     Related articles    Abstract available


    August 2006
  44. DIEFENBACH CS , Soslow RA, Iasonos A, Linkov I, et al
    Lysophosphatidic acid acyltransferase-beta (LPAAT-beta) is highly expressed in advanced ovarian cancer and is associated with aggressive histology and poor survival.
    Cancer. 2006;.
    PubMed     Related articles    Abstract available


  45. PAVELKA JC , Brown RS, Karlan BY, Cass I, et al
    Effect of obesity on survival in epithelial ovarian cancer.
    Cancer. 2006;.
    PubMed     Related articles    Abstract available


  46. KIOI M , Kawakami M, Shimamura T, Husain SR, et al
    Interleukin-13 receptor alpha2 chain: a potential biomarker and molecular target for ovarian cancer therapy.
    Cancer. 2006;.
    PubMed     Related articles    Abstract available


    July 2006
  47. KAZEROUNI N , Greene MH, Lacey JV Jr, Mink PJ, et al
    Family history of breast cancer as a risk factor for ovarian cancer in a prospective study.
    Cancer. 2006;.
    PubMed     Related articles    Abstract available


    June 2006
  48. ROCCONI RP , Case AS, Straughn JM Jr, Estes JM, et al
    Role of chemotherapy for patients with recurrent platinum-resistant advanced epithelial ovarian cancer: a cost-effectiveness analysis.
    Cancer. 2006;.
    PubMed     Related articles    Abstract available


  49. WILEY A , Katsaros D, Chen H, Rigault de la Longrais IA, et al
    Aberrant promoter methylation of multiple genes in malignant ovarian tumors and in ovarian tumors with low malignant potential.
    Cancer. 2006;.
    PubMed     Related articles    Abstract available


    May 2006
  50. WRIGHT JD , Hagemann A, Rader JS, Viviano D, et al
    Bevacizumab combination therapy in recurrent, platinum-refractory, epithelial ovarian carcinoma: a retrospective analysis.
    Cancer. 2006;.
    PubMed     Related articles    Abstract available


    April 2006
  51. GREER JB , Modugno F, Ness RB, Allen GO, et al
    Anthropometry and the risk of epithelial ovarian cancer.
    Cancer. 2006;.
    PubMed     Related articles    Abstract available


  52. MITTENDORF EA , Storrer CE, Foley RJ, Harris K, et al
    Evaluation of the HER2/neu-derived peptide GP2 for use in a peptide-based breast cancer vaccine trial.
    Cancer. 2006;.
    PubMed     Related articles    Abstract available


    March 2006
  53. CHI DS , McCaughty K, Diaz JP, Huh J, et al
    Guidelines and selection criteria for secondary cytoreductive surgery in patients with recurrent, platinum-sensitive epithelial ovarian carcinoma.
    Cancer. 2006;.
    PubMed     Related articles    Abstract available


  54. ROSEN DG , Yang G, Deavers MT, Malpica A, et al
    Cyclin E expression is correlated with tumor progression and predicts a poor prognosis in patients with ovarian carcinoma.
    Cancer. 2006;.
    PubMed     Related articles    Abstract available


Thank you for your interest in scientific medicine.


Amedeo is a Bernd Sebastian Kamps website.

   Design: